Literature DB >> 25913824

Video-assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database.

Pierre-Emmanuel Falcoz1, Marc Puyraveau2, Pascal-Alexandre Thomas3, Herbert Decaluwe4, Martin Hürtgen5, René Horsleben Petersen6, Henrik Hansen6, Alessandro Brunelli7.   

Abstract

OBJECTIVES: Video-assisted thoracoscopic anatomical resections are increasingly used in Europe to manage primary lung cancer. The purpose of this study was to compare the outcome following thoracoscopic versus open lobectomy in case-matched groups of patients from the European Society of Thoracic Surgeon (ESTS) database.
METHODS: All patients having lobectomy as the primary procedure via thoracoscopy [video-assisted thoracoscopic surgery (VATS)-L)] or thoracotomy (TH-L) were identified in the ESTS database (January 2007 to December 2013). A propensity score was constructed using several patients' baseline characteristics. The matching using the propensity score was responsible for the minimization of selection bias. A propensity score-matched analysis was performed to compare the incidence of postoperative major complications (according to the ESTS database definitions) and mortality at hospital discharge between the matched groups. After exclusions, 28 771 patients were identified: 26 050 having thoracotomy and 2721 having thoracoscopy. Propensity score yielded two well-matched groups of 2721 patients. Numeric variables were compared by Student's t-tests and categorical variables were compared by McNemar's tests.
RESULTS: Compared with TH-L, VATS-L was associated with a lower incidence of total complications [n = 792 (29.1%) vs 863 (31.7%), P = 0.0357], major cardiopulmonary complications [n = 316 (15.9%) vs 435 (19.6%), P = 0.0094], atelectasis requiring bronchoscopy [n = 65 (2.4%) vs 150 (5.5%), P < 0.0001], initial ventilation >48 h [n = 18 (0.7%) vs 38 (1.4%), P = 0.0075] and wound infection [n = 6 (0.2%) vs 17 (0.6%), P = 0.0218]. There was no difference in the incidence of postoperative atrial fibrillation between the two groups (P = 0.14). Postoperative hospital stay was 2 days shorter in the VATS-L patients (mean: 7.8 vs 9.8 days; P = 0.0003). In terms of outcome at hospital discharge, there were 27 deaths in the VATS-L group (1%) versus 50 in the TH-L group (1.9%, P = 0.0201).
CONCLUSIONS: Data from the ESTS database confirmed that lobectomy performed through VATS is associated with a lower incidence of complications compared with thoracotomy.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Database; Lobectomy; Lung cancer; Video-assisted thoracoscopic surgery

Mesh:

Year:  2015        PMID: 25913824     DOI: 10.1093/ejcts/ezv154

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  95 in total

1.  Editorial comment on: "Major morbidity after video-assisted thoracic surgery lung resections: a comparison between the European Society of Thoracic Surgeons definition and the Thoracic Morbidity and Mortality system" by Sandri A, et al.

Authors:  Pierre-Emmanuel Falcoz
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  Is it safe to perform completion lobectomy after diagnostic wedge resection using video-assisted thoracoscopic surgery?

Authors:  Bo Laksáfoss Holbek; René Horsleben Petersen; Henrik Jessen Hansen
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-02-25

Review 3.  Updates on Minimally Invasive Surgery in Non-Small Cell Lung Cancer.

Authors:  Norihiko Ikeda
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

Review 4.  An adaptation of the Hungarian model: the Brazilian model.

Authors:  Maria Teresa Ruiz Tsukazan; Ricardo Mingarini Terra; Benoit Jacques Bibas; Michele Salati
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

5.  Four arms robotic-assisted pulmonary resection-left lower lobectomy: how to do it.

Authors:  Alessandro Pardolesi; Luca Bertolaccini; Jury Brandolini; Piergiorgio Solli
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

6.  Stereotactic ablative body radiation therapy or surgery for operable early non-small cell lung cancer patients: bound hand and foot to evidence.

Authors:  Antonin Levy; Olaf Mercier; Cécile Le Péchoux
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

7.  The era of uniportal video-assisted thoracoscopic surgery.

Authors:  Monica Pastina; Cecilia Menna; Claudio Andreetti; Mohsen Ibrahim
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

8.  Risk factors and impact of conversion from VATS to open lobectomy: analysis from a national database.

Authors:  Stefano Bongiolatti; Alessandro Gonfiotti; Domenico Viggiano; Sara Borgianni; Leonardo Politi; Roberto Crisci; Carlo Curcio; Luca Voltolini
Journal:  Surg Endosc       Date:  2019-01-31       Impact factor: 4.584

9.  Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a word of caution.

Authors:  Gonzalo Varela; María Teresa Gómez-Hernández
Journal:  Transl Lung Cancer Res       Date:  2016-02

Review 10.  Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more.

Authors:  Abby White; Scott J Swanson
Journal:  J Thorac Dis       Date:  2016-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.